Kenvue Inc
KVUE21.450USD
-0.589-2.68%
Close 06/13, 16:00（ET）Quotes delayed by 15 min
41.16BMarket Cap
39.96P/E TTM
More Details of Kenvue Inc Company
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Company Info
Ticker SymbolKVUE
Company nameKenvue Inc
IPO dateMay 04, 2023
Founded at2022
CEOMr. Thibaut Mongon
Number of employees22000
Security typeOrdinary Share
Fiscal year-endMay 04
Address1 Kenvue Way
CitySUMMIT
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code07901
Phone19088741200
Websitehttps://www.kenvue.com
Ticker SymbolKVUE
IPO dateMay 04, 2023
Founded at2022
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Thibaut Mongon
Mr. Thibaut Mongon
Chief Executive Officer, Director
Chief Executive Officer, Director
216.47K
+8.04%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
64.44K
+5.82%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
56.32K
-14.66%
Ms. Bing (Ellie) Xie
Ms. Bing (Ellie) Xie
Group President, Asia Pacific
Group President, Asia Pacific
47.60K
+8.84%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.13K
+6.62%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+15.35%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
31.36K
+9.72%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.68%
Mr. Michael E. Sneed
Mr. Michael E. Sneed
Independent Director
Independent Director
28.44K
+52.59%
Mr. Larry J. Merlo
Mr. Larry J. Merlo
Independent Chairman of the Board
Independent Chairman of the Board
27.46K
+124.86%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Thibaut Mongon
Mr. Thibaut Mongon
Chief Executive Officer, Director
Chief Executive Officer, Director
216.47K
+8.04%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
64.44K
+5.82%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
56.32K
-14.66%
Ms. Bing (Ellie) Xie
Ms. Bing (Ellie) Xie
Group President, Asia Pacific
Group President, Asia Pacific
47.60K
+8.84%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.13K
+6.62%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+15.35%
Revenue Breakdown
Currency: USDUpdated: Sun, Apr 6
Currency: USDUpdated: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Face and Body Care
2.94B
19.00%
Other Self Care
2.32B
15.00%
Cough, Cold and Allergy
2.16B
14.00%
Pain Care
2.01B
13.00%
Other Essential Health
1.70B
11.00%
Other
4.33B
28.00%
By RegionUSD
Name
Revenue
Proportion
Northern America
7.58B
49.04%
Europe, Middle East, and Africa
3.56B
23.03%
Asia - Pacific
2.97B
19.24%
Latin America
1.34B
8.69%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Face and Body Care
2.94B
19.00%
Other Self Care
2.32B
15.00%
Cough, Cold and Allergy
2.16B
14.00%
Pain Care
2.01B
13.00%
Other Essential Health
1.70B
11.00%
Other
4.33B
28.00%
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.89%
T. Rowe Price Associates, Inc.
10.85%
State Street Global Advisors (US)
6.26%
BlackRock Institutional Trust Company, N.A.
4.91%
MFS Investment Management
4.85%
Other
61.23%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
11.89%
T. Rowe Price Associates, Inc.
10.85%
State Street Global Advisors (US)
6.26%
BlackRock Institutional Trust Company, N.A.
4.91%
MFS Investment Management
4.85%
Other
61.23%
Shareholder Types
Shareholders
Proportion
Investment Advisor/Hedge Fund
44.75%
Investment Advisor
44.35%
Hedge Fund
4.36%
Research Firm
3.22%
Pension Fund
1.71%
Sovereign Wealth Fund
1.40%
Bank and Trust
1.18%
Family Office
0.19%
Family Office
0.19%
Institutional Shareholding
Updated: Sun, Jan 19
Updated: Sun, Jan 19
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
2016
1.96B
102.26%
-286.97M
2024Q4
1944
1.96B
102.60%
-253.31M
2024Q3
1828
1.91B
99.61%
-331.64M
2024Q2
1723
1.90B
99.19%
-79.08M
2024Q1
1598
1.90B
99.47%
-51.94M
2023Q4
1442
1.89B
98.66%
-22.82M
2023Q3
1206
1.90B
99.22%
-343.08M
2023Q2
232
1.95B
101.85%
+1.90B
2023Q1
1
--
0.00%
-14.23K
2022Q4
1
--
0.00%
-14.23K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
217.71M
11.39%
+1.67M
+0.77%
Dec 31, 2024
T. Rowe Price Associates, Inc.
242.05M
12.66%
+8.03M
+3.43%
Dec 31, 2024
State Street Global Advisors (US)
120.40M
6.3%
-6.81M
-5.36%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
93.06M
4.87%
+2.22M
+2.44%
Dec 31, 2024
MFS Investment Management
93.86M
4.91%
+10.11M
+12.07%
Dec 31, 2024
Fidelity Management & Research Company LLC
106.19M
5.56%
-9.01M
-7.82%
Dec 31, 2024
Wellington Management Company, LLP
68.36M
3.58%
-10.72M
-13.56%
Dec 31, 2024
Geode Capital Management, L.L.C.
46.07M
2.41%
+1.39M
+3.12%
Dec 31, 2024
Harris Associates L.P.
31.52M
1.65%
+58.77K
+0.19%
Dec 31, 2024
Charles Schwab Investment Management, Inc.
24.97M
1.31%
+561.57K
+2.30%
Dec 31, 2024
View more
Related ETFs
Updated: Fri, Jun 6
Updated: Fri, Jun 6
Name
Proportion
Renaissance IPO ETF
10.35%
First Trust US Equity Opportunities ETF
3.72%
Cullen Enhanced Equity Income ETF
3.7%
Brookstone Value Stock ETF
3.69%
TBG Dividend Focus ETF
3.63%
TrueShares Low Volatility Equity Income ETF
3.38%
First Trust Dorsey Wright Momentum & Dividend ETF
2.83%
Consumer Staples Select Sector SPDR Fund
2.8%
ProShares Ultra Consumer Staples
2.75%
Invesco S&P 500 Equal Weight Consumer Staples ETF
2.65%
View more
Renaissance IPO ETF
Proportion10.35%
First Trust US Equity Opportunities ETF
Proportion3.72%
Cullen Enhanced Equity Income ETF
Proportion3.7%
Brookstone Value Stock ETF
Proportion3.69%
TBG Dividend Focus ETF
Proportion3.63%
TrueShares Low Volatility Equity Income ETF
Proportion3.38%
First Trust Dorsey Wright Momentum & Dividend ETF
Proportion2.83%
Consumer Staples Select Sector SPDR Fund
Proportion2.8%
ProShares Ultra Consumer Staples
Proportion2.75%
Invesco S&P 500 Equal Weight Consumer Staples ETF
Proportion2.65%
Dividend
A total of
2.32B
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Jan 16, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025
Feb 12, 2025
Feb 26, 2025
Feb 12, 2025
Oct 17, 2024
KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 27, 2024
Nov 13, 2024
Jul 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024
Aug 14, 2024
Aug 28, 2024
Aug 14, 2024
Apr 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024
May 08, 2024
May 22, 2024
May 07, 2024
Jan 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024
Feb 14, 2024
Feb 28, 2024
Feb 13, 2024
Oct 26, 2023
KVUE.NB Final Cash Dividend of gross USD 0.2 paid on Nov 22, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 22, 2023
Nov 07, 2023
Jul 20, 2023
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 07, 2023 going ex on Aug 25, 2023
Aug 28, 2023
Sep 07, 2023
Aug 25, 2023
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
